EKSO — Ekso Bionics Holdings Inc
NASDAQ · Healthcare · Medical Instruments & Supplies
Ekso Bionics Holdings Inc (EKSO) is a medical instruments & supplies company listed on NASDAQ. It is led by Scott G. Davis, based in 101 Glacier Point, San Rafael, CA, United States, 94901, with about 50 employees. Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Net income was -$1.4M. EKSO currently screens at market cap $42.0M.
Use this EKSO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the EKSO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the EKSO SEC filings page. Lician reads the product cache first so this HTML stays unique to Ekso Bionics Holdings Inc even when a live quote feed is slow.
About Ekso Bionics Holdings Inc
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
EKSO Key Statistics
Market Cap
$42.05M
P/B Ratio
19.86
EPS
$0.00
Revenue
$0.00
Net Income
-$11.33M
Gross Profit
$0.00
Free Cash Flow
$0.00
Employees
50
EKSO Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$11.33M | -$15.20M | -$15.08M | -$9.76M |
| EPS (Diluted) | $0.00 | -$1.10 | -$1.16 | -$0.88 |
Total Assets
$26.65M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$6.49M
Operating Cash Flow
-$9.85M
Free Cash Flow
$0.00
Ekso Bionics Holdings Inc Company Information
- CEO & Director
- Scott G. Davis
- Headquarters
- 101 Glacier Point, San Rafael, CA, United States, 94901
- Website
- www.eksobionics.com
- Phone
- 510 984 1761
- IPO / Founded
- 2014-01-16
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies